+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • PDF Icon

    Report

  • 435 Pages
  • September 2025
  • Region: North America
  • GlobalData
  • ID: 6173488
The “North America Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests

ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The North America Oncology Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share data for Oncology Market.
  • Global corporate-level profiles of key companies operating within the North America Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Oncology is segmented as follows:

  • Colorectal Cancer Screening Tests
  • EGFR Tests
  • KRAS Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • BRAF Tests
  • BCR-ABL Tests
  • PD-L1 Tests

Reasons to Buy

The North America Oncology Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Oncology Market, North America
3.1 Oncology Market, North America, Revenue ($m), 2018-2033
3.2 Oncology Market, North America, Revenue ($m), 2018-2033
3.3 Oncology Market, North America, Volume (Units), 2018-2033
3.4 Oncology Market, North America, Volume (Units), 2018-2033
3.5 Oncology Market, North America, Company Share by Revenue ($m), 2024
4 Oncology Market, Canada
4.1 Oncology Market, Canada, Revenue ($m), 2018-2033
4.1.1 ALK Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.2 BCR-ABL Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.3 BRAF Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.4 BRCA Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.5 Colorectal Cancer Screening Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.6 EGFR Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.7 HER2 Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.8 KRAS Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, Canada, Volume (Units), 2018-2033
4.2.1 ALK Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.2 BCR-ABL Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.3 BRAF Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.4 BRCA Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.5 Colorectal Cancer Screening Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.6 EGFR Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.7 HER2 Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.8 KRAS Tests Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Oncology Market, Canada, Average Price ($) , 2018-2033
4.4 Oncology Market, Canada, Company Share by Revenue ($m), 2024
5 Oncology Market, Mexico
5.1 Oncology Market, Mexico, Revenue ($m), 2018-2033
5.1.1 ALK Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.2 BCR-ABL Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.3 BRAF Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.4 BRCA Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.5 Colorectal Cancer Screening Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.6 EGFR Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.7 HER2 Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.1.8 KRAS Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033
5.2 Oncology Market, Mexico, Volume (Units), 2018-2033
5.2.1 ALK Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.2 BCR-ABL Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.3 BRAF Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.4 BRCA Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.5 Colorectal Cancer Screening Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.6 EGFR Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.7 HER2 Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
5.2.8 KRAS Tests Market, Mexico, Volume (Units), by Segment, 2018-2033
5.3 Oncology Market, Mexico, Average Price ($) , 2018-2033
5.4 Oncology Market, Mexico, Company Share by Revenue ($m), 2024
6 Oncology Market, United States7 Overview of Key Companies in United States, Oncology Market8 Recent Developments
9 Appendix
9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the analyst Consulting
9.3 Contact the Publisher
9.4 Disclaimer
List of Tables
Table 1: Oncology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Table 2: Oncology Market, North America, Revenue ($m), USD Constant, 2018-2033
Table 3: Oncology Market, North America, Volume (Units), 2018-2033
Table 4: Oncology Market, North America, Volume (Units), 2018-2033
Table 5: Oncology Market, North America, Company Share by Revenue ($m), 2024
Table 6: Oncology Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 7: ALK Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 8: BCR-ABL Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 9: BRAF Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 10: BRCA Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 11: Colorectal Cancer Screening Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 12: EGFR Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 13: HER2 Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 14: KRAS Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 15: Oncology Market, Canada, Volume (Units), 2018-2033
Table 16: ALK Tests Market, Canada, Volume (Units), 2018-2033
Table 17: BCR-ABL Tests Market, Canada, Volume (Units), 2018-2033
Table 18: BRAF Tests Market, Canada, Volume (Units), 2018-2033
Table 19: BRCA Tests Market, Canada, Volume (Units), 2018-2033
Table 20: Colorectal Cancer Screening Tests Market, Canada, Volume (Units), 2018-2033
Table 21: EGFR Tests Market, Canada, Volume (Units), 2018-2033
Table 22: HER2 Tests Market, Canada, Volume (Units), 2018-2033
Table 23: KRAS Tests Market, Canada, Volume (Units), 2018-2033
Table 24: Oncology Market, Canada, Average Price ($), 2018-2033
Table 25: Oncology Market, Canada, Company Share by Revenue ($m), 2024
Table 26: Oncology Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 27: ALK Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 28: BCR-ABL Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 29: BRAF Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 30: BRCA Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 31: Colorectal Cancer Screening Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 32: EGFR Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 33: HER2 Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 34: KRAS Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 35: Oncology Market, Mexico, Volume (Units), 2018-2033
Table 36: ALK Tests Market, Mexico, Volume (Units), 2018-2033
Table 37: BCR-ABL Tests Market, Mexico, Volume (Units), 2018-2033
Table 38: BRAF Tests Market, Mexico, Volume (Units), 2018-2033
Table 39: BRCA Tests Market, Mexico, Volume (Units), 2018-2033
Table 40: Colorectal Cancer Screening Tests Market, Mexico, Volume (Units), 2018-2033
Table 41: EGFR Tests Market, Mexico, Volume (Units), 2018-2033
Table 42: HER2 Tests Market, Mexico, Volume (Units), 2018-2033
Table 43: KRAS Tests Market, Mexico, Volume (Units), 2018-2033
Table 44: Oncology Market, Mexico, Average Price ($), 2018-2033
Table 45: Oncology Market, Mexico, Company Share by Revenue ($m), 2024
Table 46: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 47: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 48: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 49: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 50: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 51 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 52: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 53: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 54: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 55: Oncology Market, United States, Volume (Units), 2018-2033
Table 56: ALK Tests Market, United States, Volume (Units), 2018-2033
Table 57: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033
Table 58: BRAF Tests Market, United States, Volume (Units), 2018-2033
Table 59: BRCA Tests Market, United States, Volume (Units), 2018-2033
Table 60: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033
Table 61: EGFR Tests Market, United States, Volume (Units), 2018-2033
Table 62: HER2 Tests Market, United States, Volume (Units), 2018-2033
Table 63: KRAS Tests Market, United States, Volume (Units), 2018-2033
Table 64: Oncology Market, United States, Average Price ($), 2018-2033
Table 65: Oncology Market, United States, Company Share by Revenue ($m), 2024
Table 66: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Oncology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Figure 2: Oncology Market, North America, Revenue ($m), USD Constant, 2018-2033
Figure 3: Oncology Market, North America, Volume (Units), 2018-2033
Figure 4: Oncology Market, North America, Volume (Units), 2018-2033
Figure 5: Oncology Market, North America, Company Share (%), 2024
Figure 6: Oncology Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: ALK Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 8: BCR-ABL Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 9: BRAF Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 10: BRCA Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 11: Colorectal Cancer Screening Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 12: EGFR Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 13: HER2 Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 14: KRAS Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 15: Oncology Market, Canada, Volume (Units), 2018-2033
Figure 16: ALK Tests Market, Canada, Volume (Units), 2018-2033
Figure 17: BCR-ABL Tests Market, Canada, Volume (Units), 2018-2033
Figure 18: BRAF Tests Market, Canada, Volume (Units), 2018-2033
Figure 19: BRCA Tests Market, Canada, Volume (Units), 2018-2033
Figure 20: Colorectal Cancer Screening Tests Market, Canada, Volume (Units), 2018-2033
Figure 21: EGFR Tests Market, Canada, Volume (Units), 2018-2033
Figure 22: HER2 Tests Market, Canada, Volume (Units), 2018-2033
Figure 23: KRAS Tests Market, Canada, Volume (Units), 2018-2033
Figure 24: Oncology Market, Canada, Company Share (%), 2024
Figure 25: Oncology Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 26: ALK Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 27: BCR-ABL Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 28: BRAF Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 29: BRCA Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 30: Colorectal Cancer Screening Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 31: EGFR Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 32: HER2 Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 33: KRAS Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 34: Oncology Market, Mexico, Volume (Units), 2018-2033
Figure 35: ALK Tests Market, Mexico, Volume (Units), 2018-2033
Figure 36: BCR-ABL Tests Market, Mexico, Volume (Units), 2018-2033
Figure 37: BRAF Tests Market, Mexico, Volume (Units), 2018-2033
Figure 38: BRCA Tests Market, Mexico, Volume (Units), 2018-2033
Figure 39: Colorectal Cancer Screening Tests Market, Mexico, Volume (Units), 2018-2033
Figure 40: EGFR Tests Market, Mexico, Volume (Units), 2018-2033
Figure 41: HER2 Tests Market, Mexico, Volume (Units), 2018-2033
Figure 42: KRAS Tests Market, Mexico, Volume (Units), 2018-2033
Figure 43: Oncology Market, Mexico, Company Share (%), 2024
Figure 44: Oncology Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 45: ALK Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 46: BCR-ABL Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 47: BRAF Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 48: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 49: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 50: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 51: HER2 Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 52: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 53: Oncology Market, United States, Volume (Units), 2018-2033
Figure 54: ALK Tests Market, United States, Volume (Units), 2018-2033
Figure 55: BCR-ABL Tests Market, United States, Volume (Units), 2018-2033
Figure 56: BRAF Tests Market, United States, Volume (Units), 2018-2033
Figure 57: BRCA Tests Market, United States, Volume (Units), 2018-2033
Figure 58: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2018-2033
Figure 59: EGFR Tests Market, United States, Volume (Units), 2018-2033
Figure 60: HER2 Tests Market, United States, Volume (Units), 2018-2033
Figure 61: KRAS Tests Market, United States, Volume (Units), 2018-2033
Figure 62: Oncology Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Exact Sciences Corp
  • Agilent Technologies Inc
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Qiagen NV
  • Danaher Corp
  • Guardant Health Inc
  • Thermo Fisher Scientific Inc
  • BioGenex Laboratories Inc
  • Bio-Techne Corp